DBG
De Burlo Group Portfolio holdings
AUM
$759M
This Quarter Return
+18.38%
1 Year Return
+24.77%
3 Year Return
+146.35%
5 Year Return
+326.03%
10 Year Return
+1,922.48%
AUM
$533M
AUM Growth
+$533M
(+13%)
Cap. Flow
+$880K
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
34.62%
Holding
127
New
21
Increased
12
Reduced
51
Closed
17
Top Buys
| 1 |
TJX Companies
TJX
|
$10.3M |
| 2 |
Centene
CNC
|
$9.5M |
| 3 |
Progressive
PGR
|
$8.84M |
| 4 |
Illumina
ILMN
|
$8.53M |
| 5 |
Eli Lilly
LLY
|
$8.36M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$15.1M |
| 2 |
Netflix
NFLX
|
$14.3M |
| 3 |
PFPT
Proofpoint, Inc.
PFPT
|
$9.77M |
| 4 |
ETFC
E*Trade Financial Corporation
ETFC
|
$9.73M |
| 5 |
Qualys
QLYS
|
$8.39M |
Sector Composition
| 1 | Healthcare | 28.53% |
| 2 | Technology | 28.17% |
| 3 | Financials | 13.94% |
| 4 | Consumer Discretionary | 11.92% |
| 5 | Industrials | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GHDX
51
DELISTED
Genomic Health, Inc.
GHDX
| $3.29M | 0.62% |
+46,900
| New | +$3.29M |
|
52
Danaher
DHR
$145B
| $3.27M | 0.61% |
30,050
| – | – |
|
53
Edwards Lifesciences
EW
$48B
| $3.22M | 0.6% |
18,500
-38,000
| -67% | -$6.62M |
|
54
Berkshire Hathaway Class B
BRK.B
$1.08T
| $2.93M | 0.55% |
13,700
| – | – |
|
|
ALXN
55
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.78M | 0.52% |
19,996
| – | – |
|
56
Henry Schein
HSIC
$8.29B
| $2.77M | 0.52% |
32,610
-400
| -1% | -$34K |
|
57
Stryker
SYK
$149B
| $2.73M | 0.51% |
15,350
-15,600
| -50% | -$2.77M |
|
58
Capri Holdings
CPRI
$2.43B
| $2.65M | 0.5% |
+38,600
| New | +$2.65M |
|
59
Starbucks
SBUX
$101B
| $2.61M | 0.49% |
45,900
-600
| -1% | -$34.1K |
|
60
Sysco
SYY
$38.5B
| $2.6M | 0.49% |
+35,500
| New | +$2.6M |
|
61
Masimo
MASI
$7.41B
| $2.48M | 0.46% |
19,900
-200
| -1% | -$24.9K |
|
62
Microchip Technology
MCHP
$34.1B
| $2.47M | 0.46% |
31,350
-400
| -1% | -$31.6K |
|
63
3M
MMM
$82.1B
| $2.39M | 0.45% |
11,351
-160
| -1% | -$33.7K |
|
64
Robert Half
RHI
$3.81B
| $2.32M | 0.43% |
+32,900
| New | +$2.32M |
|
65
A.O. Smith
AOS
$9.86B
| $2.29M | 0.43% |
43,000
-900
| -2% | -$48K |
|
66
MKS Inc. Common Stock
MKSI
$6.74B
| $2.22M | 0.42% |
27,700
-250
| -0.9% | -$20K |
|
|
67
Netflix
NFLX
$515B
| $2.18M | 0.41% |
5,830
-38,150
| -87% | -$14.3M |
|
68
Neurocrine Biosciences
NBIX
$14B
| $2.08M | 0.39% |
16,900
| – | – |
|
69
Guidewire Software
GWRE
$18.1B
| $2.03M | 0.38% |
20,100
-13,700
| -41% | -$1.38M |
|
70
Atmos Energy
ATO
$26.6B
| $2.01M | 0.38% |
21,400
-900
| -4% | -$84.5K |
|
71
Gilead Sciences
GILD
$139B
| $1.96M | 0.37% |
25,375
-900
| -3% | -$69.5K |
|
72
Crown Castle
CCI
$42.6B
| $1.82M | 0.34% |
16,350
| – | – |
|
|
ESRX
73
DELISTED
Express Scripts Holding Company
ESRX
| $1.82M | 0.34% |
19,155
-200
| -1% | -$19K |
|
74
Verizon
VZ
$184B
| $1.82M | 0.34% |
34,015
| – | – |
|
75
Nike
NKE
$110B
| $1.46M | 0.27% |
17,200
-100
| -0.6% | -$8.47K |
|